Ghrelin inhibits vascular superoxide production in spontaneously hypertensive rats

被引:84
作者
Kawczynska-Drozdz, Agnieszka
Olszanecki, Rafal
Jawien, Jacek
Brzozowski, Tomasz
Pawlik, Wieslaw W.
Korbut, Ryszard
Guzik, Tomasz J.
机构
[1] Emory Univ, Sch Med, Div Cardiol, Atlanta, GA 30322 USA
[2] Jagiellonian Univ, Sch Med, J Dietl Hosp, Dept Pharmacol, Krakow, Poland
[3] Jagiellonian Univ, Sch Med, J Dietl Hosp, Dept Physiol, Krakow, Poland
[4] Jagiellonian Univ, Sch Med, J Dietl Hosp, Dept Internal Med, Krakow, Poland
基金
英国惠康基金;
关键词
superoxide; ghrelin; oxidative stress; nitric oxide; hypertension; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION; NAD(P)H OXIDASE; ANGIOTENSIN-II; NITRIC-OXIDE; MECHANISMS; PRESSURE;
D O I
10.1016/j.amjhyper.2006.01.022
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Ghrelin is a novel peptide involved in the control of appetite, but its role in vascular pathologies remains to be elucidated. Ghrelin was shown to decrease blood pressure (BP) and improve endothelial function. Its plasma levels are correlated with BP in humans. Mechanisms of these effects are unknown. Because oxidative stress and increased superoxide production by NAD(P)H oxidases (Nox) are critical in the pathogenesis of hypertension, we aimed to study the effects of ghrelin on vascular superoxide production and NAD(P)H oxidase activity in spontaneously hypertensive rats (SHR). Methods: Aortic superoxide production and NAD(P)H oxidase activity were measured using lucigenin (5 mu mol/L) chemiluminescence. Aortas from Wistar-Kyoto rats (WKY) were used as control. Direct superoxide scavenging properties of ghrelin were tested using xanthine-xanthine oxidase system. Results: Both basal superoxide production and vascular NADPH oxidase activity were significantly higher in aortas from SHR, than from WKY. Preincubation of aortic segments from SHR or WKY with ghrelin caused concentration-dependent (from 50 pg/mL to 5 ng/mL) decrease of basal superoxide production. Vascular NAD(P)H oxidase activity was inhibited by ghrelin, abolishing the difference between SHR and basal WKY. Ghrelin did not affect superoxide release from the in vitro xanthine-xanthine oxidase system, indicating lack of direct superoxide scavenging properties or inhibitory effects on xanthine oxidase in vitro. Nitric oxide synthase (NOS) inhibition, using N-omega-nitro-L-arginine methyl ester (L-NAME), partially blunted the effects of ghrelin on NADPH oxidase activity indicating potential role of nitric oxide. Conclusions: Ghrelin inhibits vascular oxidative stress in SHR. This effect is likely related to the inhibition of vascular NAD(P)H oxidases. Am J Hypertens 2006; 19:764-767 (c) 2006 American Journal of Hypertension, Ltd.
引用
收藏
页码:764 / 767
页数:4
相关论文
共 15 条
[1]   NITRIC-OXIDE, AN ENDOTHELIAL-CELL RELAXATION FACTOR, INHIBITS NEUTROPHIL SUPEROXIDE ANION PRODUCTION VIA A DIRECT ACTION ON THE NADPH OXIDASE [J].
CLANCY, RM ;
LESZCZYNSKAPIZIAK, J ;
ABRAMSON, SB .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03) :1116-1121
[2]   Systemic regulation of vascular NAD(P)H oxidase activity and nox isoform expression in human arteries and veins [J].
Guzik, TJ ;
Sadowski, J ;
Kapelak, B ;
Jopek, A ;
Rudzinski, P ;
Pillai, R ;
Korbut, R ;
Channon, KM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (09) :1614-1620
[3]   [125I-His9]-Ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue;: up-regulation of receptors with atherosclerosis [J].
Katugampola, SD ;
Pallikaros, Z ;
Davenport, AP .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (01) :143-149
[4]   Role of p47phox in vascular oxidative stress and hypertension caused by angiotensin II [J].
Landmesser, U ;
Cai, H ;
Dikalov, S ;
McCann, L ;
Hwang, J ;
Jo, H ;
Holland, SM ;
Harrison, DG .
HYPERTENSION, 2002, 40 (04) :511-515
[5]   Ghrelin blunted vascular calcification in vivo and in vitro in rats [J].
Li, GZ ;
Jiang, W ;
Zhao, J ;
Pan, CS ;
Cao, J ;
Tang, CS ;
Chang, L .
REGULATORY PEPTIDES, 2005, 129 (1-3) :167-176
[6]   Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells [J].
Li, WG ;
Gavrila, D ;
Liu, XB ;
Wang, LX ;
Gunnlaugsson, S ;
Stoll, LL ;
McCormick, ML ;
Sigmund, CD ;
Tang, CS ;
Weintraub, NL .
CIRCULATION, 2004, 109 (18) :2221-2226
[7]   Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats [J].
Lin, YZ ;
Matsumura, K ;
Fukuhara, M ;
Kagiyama, S ;
Fujii, K ;
Iida, M .
HYPERTENSION, 2004, 43 (05) :977-982
[8]   Alteration of plasma ghrelin levels associated with the blood pressure in pregnancy [J].
Makino, Y ;
Hosoda, H ;
Shibata, K ;
Makino, I ;
Kojima, M ;
Kangawa, K ;
Kawarabayashi, T .
HYPERTENSION, 2002, 39 (03) :781-784
[9]   Growth hormone secretagogue binding sites in peripheral human tissues [J].
Papotti, M ;
Ghè, C ;
Cassoni, P ;
Catapano, F ;
Deghenghi, R ;
Ghigo, E ;
Muccioli, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3803-3807
[10]   Obesity-associated hypertension - New insights into mechanisms [J].
Rahmouni, K ;
Correia, MLG ;
Haynes, WG ;
Mark, AL .
HYPERTENSION, 2005, 45 (01) :9-14